Milan Valeska, Fetzer Stefan
Fakultät Wirtschaftswissenschaften, Studienbereich Gesundheitsmanagement, Hochschule Aalen, Beethovenstr. 1, 73430, Aalen, Deutschland.
AOK Baden-Württemberg, Stuttgart, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Aug;62(8):993-1003. doi: 10.1007/s00103-019-02981-3.
Dementia is one of the most frequent diseases of people aged 65 and older. As a result of the upcoming demographic transition, a significant increase is expected to the current number of around 1.7 million dementia patients. A precise estimate of this increase is especially important for decision-makers and payers to the health-care system. This study examined the effects of different assumptions on the future frequency of disease using a time-discrete Markov model with population-related and disease-specific components. Based on health insurers' administrative data from AOK Baden-Württemberg, we determined age- and gender-specific prevalence rates, incidence rates, and mortality differences of dementia patients and combined them with demographic components from German population statistics. As a result, our Markov model showed a 20 to 25% higher number of dementia patients in 2030, compared to the results of the status quo projection applied in most previous studies, with the assumption of constant prevalence rates over time. Hence, our results indicate that even in the medium term payers will have to face significant increases in dementia-related health expenditures. By 2060, the number of dementia patients in Germany would rise to 3.3 million assuming a further increase to life expectancy and constant incidence rates over time. The assumption of a compression of the morbidity would reduce this number to 2.6 million.
痴呆症是65岁及以上人群中最常见的疾病之一。由于即将到来的人口结构转变,预计目前约170万痴呆症患者的数量将大幅增加。对于医疗保健系统的决策者和支付方而言,准确估计这一增长尤为重要。本研究使用一个包含人口相关和疾病特定成分的时间离散马尔可夫模型,考察了不同假设对未来疾病发生率的影响。基于巴登-符腾堡州AOK健康保险公司的管理数据,我们确定了痴呆症患者的年龄和性别特异性患病率、发病率及死亡率差异,并将其与德国人口统计中的人口成分相结合。结果显示,与大多数以往研究采用的现状预测结果相比,我们的马尔可夫模型表明,在假设患病率随时间保持不变的情况下,2030年痴呆症患者数量将高出20%至25%。因此,我们的结果表明,即使在中期,支付方也将不得不面对与痴呆症相关的医疗支出大幅增加的情况。假设预期寿命进一步延长且发病率随时间保持不变,到2060年,德国痴呆症患者数量将增至330万。假设发病期缩短,这一数字将减至260万。